skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure elucidation of 3-[1-(6-methoxy-2-naphtyl)ethyl]-6-(2,4-dichlorophenyl)-7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine, C23H18Cl2N4OS from synchrotron X-ray powder diffraction

Journal Article · · Powder Diffraction

The 3-[1-(6-methoxy-2-naphtyl)ethyl]-6-(2,4-dichlorophenyl)-7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine, C23H18Cl2N4OS compound was synthesized, as a member of the family of novel potential anticancer agents. The structure of the title compound was characterized by IR,1H-NMR, mass spectroscopy, and elemental analysis, previously. In this study, the crystal structure of this compound has been determined from synchrotron X-ray powder diffraction data. The crystal structure was solved by simulated annealing and the final structure was achieved by Rietveld refinement method using soft restrains on all interatomic bond lengths and angles. This compound crystallizes in space groupP21,Z= 2, with the unit-cell parametersa= 15.55645(11) Å,b= 8.61693(6) Å,c= 8.56702(6) Å,β= 104.3270(4)°, andV= 1112.68(1) Å3. In the crystal structure, strong C-H∙∙∙πand weak intermolecular hydrogen-bonding interactions link the molecules into a three-dimensional network. The molecules are in a head-to-head arrangement in the unit cell.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
FOREIGN
OSTI ID:
1417392
Journal Information:
Powder Diffraction, Vol. 32, Issue 04; ISSN 0885-7156
Publisher:
Cambridge University Press
Country of Publication:
United States
Language:
ENGLISH

References (30)

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement journal May 2009
Cancer drug discovery by repurposing: teaching new tricks to old dogs journal September 2013
DASH : a program for crystal structure determination from powder diffraction data journal November 2006
Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors journal November 2009
WinGX and ORTEP for Windows : an update journal July 2012
A fully automatic program for finding the unit cell from powder data journal August 1969
2-(6-Phenyl-7 H -1,2,4-triazolo[3,4- b ][1,3,4]thiadiazin-3-yl)-1,3-benzothiazole journal September 2011
Recent advances in magnetic structure determination by neutron powder diffraction journal October 1993
Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines journal May 2014
New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: Synthesis and anticancer evaluation journal May 2007
Single-crystal structure validation with the program PLATON journal January 2003
Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase journal May 2008
OLEX2 : a complete structure solution, refinement and analysis program journal January 2009
Rietveld refinement of Debye–Scherrer synchrotron X-ray data from Al 2 O 3 journal April 1987
Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: Synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis journal November 2014
Indexing of powder diffraction patterns for low-symmetry lattices by the successive dichotomy method journal December 1991
EXPO2013 : a kit of tools for phasing crystal structures from powder data journal July 2013
Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety journal December 2009
A correction for powder diffraction peak asymmetry due to axial divergence journal December 1994
New techniques for indexing: N-TREOR in EXPO journal August 2000
A joint theoretical and experimental structural study of two novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine derivatives journal April 2010
Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents journal July 2009
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform journal August 2012
Mercury : visualization and analysis of crystal structures journal May 2006
Monte Carlo indexing with McMaille journal September 2004
CRYSTALS enhancements: dealing with hydrogen atoms in refinement journal August 2010
Synthesis of 3,6-disubstituted 7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines as novel analgesic/anti-inflammatory compounds journal November 2009
An X-ray powder diffraction study of cis -dichloridobis(2-methyl-2 H -tetrazol-5-amine-κ N 4 )platinum(II), a tetrazole-containing analogue of cisplatin journal May 2011
Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins journal February 2016
( Z )-7-[2-(4-Bromophenyl)hydrazin-1-ylidene]-6-methyl-3-(pyridin-4-yl)-7 H -1,2,4-triazolo[3,4- b ][1,3,4]thiadiazine journal April 2012